FDA Gives Mylan Tentative OK On Generic Femara
Mylan Pharmaceuticals Inc. has moved closer to regulatory approval to make generic Femara, the drug maker said Thursday, raising the stakes in a patent infringement suit Germany's Novartis AG filed to...To view the full article, register now.
Already a subscriber? Click here to view full article